← Evidence map

ReviewMedComm2023

Blood-derived product therapies for SARS-CoV-2 infection and long COVID.

Junzheng Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 38020714